MENU

CLSD Clearside Biomedical Forecast, Technical & Fundamental Analysis

a developer of drug therapies to treat chronic, blinding diseases of the eye

Industry Biotechnology
CLSD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
CLSD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CLSD is expected to report earnings to rise 4.30% to -10 cents per share on March 18

Clearside Biomedical CLSD Stock Earnings Reports
Q4'24
Est.
$-0.10
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.03
Q1'24
Missed
by $0.03
Q4'23
Beat
by $0.01
The last earnings report on November 12 showed earnings per share of -10 cents, beating the estimate of -11 cents. With 513.41K shares outstanding, the current market capitalization sits at 73.57M.
A.I. Advisor
published General Information

General Information

a developer of drug therapies to treat chronic, blinding diseases of the eye

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
900 North Point Parkway
Phone
+1 678 270-3631
Employees
30
Web
https://www.clearsidebio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

CLSD and Stocks

Correlation & Price change

A.I.dvisor tells us that CLSD and ACLX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLSD and ACLX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLSD
1D Price
Change %
CLSD100%
+0.99%
ACLX - CLSD
28%
Poorly correlated
-1.67%
INBX - CLSD
28%
Poorly correlated
-0.07%
ATRA - CLSD
27%
Poorly correlated
-1.52%
JAZZ - CLSD
26%
Poorly correlated
-2.16%
IKNA - CLSD
26%
Poorly correlated
+0.62%
More